A seven-year analysis of more than 119,000 hospitalized children in China has produced the largest single-center real-world dataset yet compiled on childhood immunoglobulin A vasculitis, and its findings challenge some long-standing assumptions about what sets the disease in motion. The retrospective study, drawing on inpatient discharge abstracts from Beijing Children’s Hospital, Capital Medical University, between January 2016 and December 2022, found that Mycoplasma pneumoniae was by far the most frequently recorded pathogen among these young patients, appearing in 5.82 percent of cases. That figure stands in stark contrast to Streptococcus pneumoniae, recorded in just 0.32 percent of patients, an eighteen-fold difference that sits awkwardly beside the traditional emphasis on streptococcal triggers of this condition.
Immunoglobulin A vasculitis, known until the 2012 Chapel Hill Consensus Conference as Henoch-Schonlein purpura, is the most common systemic small-vessel vasculitis of childhood. It arises when IgA1-dominant immune complexes deposit in small blood vessels, producing the classic tetrad of non-thrombocytopenic palpable purpura, joint pain and swelling, gastrointestinal involvement, and kidney disease. Although most pediatric cases resolve on their own, renal involvement, termed IgAV nephritis, is the most important long-term prognostic factor, with up to 1 to 7 percent of affected children progressing to end-stage renal disease. Reported annual incidence rates range from 3 to 27 per 100,000 children, with marked geographic and seasonal variation.
The new study enrolled 119,217 patients aged 18 years or younger with a primary IgAV diagnosis, defined according to the EULAR/PRINTO/PRES 2008 classification criteria. Children with vasculitis secondary to other systemic diseases, malignancies, or drug exposure were excluded, and only the first hospitalization record was retained for patients with multiple admissions to avoid double counting. The mean age of the cohort was 7.79 years, with a standard deviation of 3.17, and boys outnumbered girls by a ratio of 1.30 to 1, a statistically significant male predominance. School-aged children made up just over half of all cases at 50.77 percent, while infants and toddlers were strikingly rare, accounting for only 99 cases, or 0.08 percent of the total.
The age pattern traced a well-defined arc: extremely low in infancy, rising steeply in early school age, peaking in mid-childhood, and declining again in adolescence. The study’s authors note that this trajectory closely parallels the age-dependent curve of respiratory infection exposure and school contact density, a pattern consistent with the hypothesis that cumulative infection exposure and immune maturation shape disease risk. Han ethnicity accounted for 93.27 percent of patients, and the geographic distribution was far from uniform. Southern China contributed 57.91 percent of cases compared with 42.09 percent from the north, and rural areas supplied 56.91 percent of admissions against 42.21 percent from urban settings, both differences statistically significant.
Perhaps the most striking geographic finding was an east-west gradient of disease burden. East China recorded 46,256 cases, or 38.80 percent of the cohort, while Northeast China recorded just 3,516 cases, or 2.95 percent, a roughly thirteen-fold difference. The authors caution that referral patterns almost certainly influence this distribution, since Beijing Children’s Hospital is a national referral center, but they point out that the pattern is broadly consistent with previous Chinese multicenter studies. The southern predominance, they note, aligns with nationwide epidemiological analyses, and earlier meteorological correlation studies have confirmed associations between climatic humidity, temperature, and IgAV incidence.
Seasonality told a similarly emphatic story. The winter-spring period from November through March concentrated 50.66 percent of all cases, with December the busiest admission month at 13,924 cases and July the quietest at 5,922. This peak overlaps precisely with the winter epidemics of influenza, respiratory syncytial virus, and Mycoplasma pneumoniae documented in China, providing temporal support for the infection-driven hypothesis of IgAV onset. Notably, Mycoplasma pneumoniae itself shows a well-documented winter-spring predominance in China, suggesting that Mycoplasma epidemics may be a key driver of the seasonal IgAV peak beyond general respiratory viral circulation.
Infection data were derived from co-recorded discharge diagnosis codes rather than standardized laboratory testing, an important caveat. Still, the numbers were substantial: 47.49 percent of patients had co-recorded infections, with upper respiratory tract infection dominating at 73.68 percent of those, followed by lower respiratory infection at 24.19 percent. After Mycoplasma pneumoniae, Helicobacter pylori and Epstein-Barr virus were the second and third most commonly identified pathogens. The authors acknowledge that Mycoplasma’s seasonal overlap with IgAV onset is a non-negligible confounding factor, but they argue that Streptococcus pneumoniae, which shares the same winter-spring epidemic window, was recorded at only 0.32 percent, suggesting that seasonal coincidence alone cannot explain the Mycoplasma predominance. Whether Mycoplasma plays a direct pathogenic role or is merely a concurrent winter infection cannot be determined from these data.
On the clinical classification front, the unspecified subtype dominated at 57.02 percent, a figure the authors attribute largely to the limitations of ICD-10 coding in capturing nuanced IgAV phenotypes. Renal-type disease was the largest organ-specific category at 20.04 percent, followed by mixed at 9.99 percent, abdominal at 6.79 percent, skin at 3.61 percent, and articular at 2.56 percent. The proportion of renal-type cases rose steadily over the study period, from 15.5 percent in 2016 to 27.0 percent in 2022, while the skin-only subtype declined from 6.4 percent to 3.2 percent. The authors urge caution in interpreting this trend, noting three overlapping possible explanations: increased urinalysis screening over time, improved coding specificity for renal involvement, and potential genuine epidemiological change. Because the subtype analysis rests only on the 42.98 percent of cases with organ-specific coding, physicians may have preferentially assigned renal codes to more severe patients, meaning the reported distribution should be read as a minimum estimate of organ-specific involvement rather than a true population prevalence.
The molecular backdrop to these findings involves the aberrant production of galactose-deficient IgA1 following mucosal infections, leading to immune complex formation, vascular deposition, and complement activation. In the kidney, these complexes lodge in the glomerular mesangium and are internalized via transferrin receptor-mediated endocytosis, activating mesangial cells and triggering complement through the lectin and alternative pathways. Mycoplasma pneumoniae surface lipoproteins can activate TLR2/TLR6-mediated innate immune signaling, potentially promoting polyclonal B-cell activation and overproduction of galactose-deficient IgA1 in genetically susceptible individuals, though the authors stress that no biomarker or biopsy data were available in this cohort, so these mechanisms remain inferential. Helicobacter pylori and Epstein-Barr virus may contribute through chronic antigenic stimulation and persistent B-cell activation, respectively.
Across the seven organ systems examined, digestive complications were the most prevalent, affecting 4.97 percent of patients, while cardiovascular comorbidities led the comorbidity profile at 1.81 percent. Rare but serious neurological complications appeared as well, including 27 cases of posterior reversible encephalopathy syndrome, a condition linked to acute hypertension-induced cerebrovascular autoregulatory failure that carries a risk of neurological sequelae. The study’s limitations are considerable: only inpatient records were analyzed, missing mild outpatient cases; infection data came from non-standardized discharge codes; and long-term renal follow-up was unavailable. Annual case volumes also fell from a peak of 21,358 in 2018 to 11,425 in 2022, a decline consistent with reduced respiratory pathogen circulation during the COVID-19 pandemic alongside changes in healthcare-seeking behavior. The authors propose that systematic multi-pathogen screening, including for Mycoplasma pneumoniae, and standardized long-term urinalysis follow-up may be warranted in managing hospitalized children with IgAV, framing the rising renal-type proportion as a signal for clinical vigilance rather than definitive evidence of worsening disease.
Subject of Research: Epidemiology and clinical characteristics of hospitalized children with immunoglobulin A vasculitis in China
Article Title: Characteristics of hospitalized children with immunoglobulin A vasculitis: a 7-year retrospective study of 119,217 pediatric inpatients in China
Article References: Ma, Y., Wang, X., Zhang, N., Liu, C., Mo, X., Hou, Y., & He, Q. (2026). Characteristics of hospitalized children with immunoglobulin A vasculitis: a 7-year retrospective study of 119,217 pediatric inpatients in China. Frontiers in Pediatrics, 14, 1965302. https://doi.org/10.3389/fped.2026.1965302
Image Credits: AI Generated
DOI: 10.3389/fped.2026.1965302
Keywords: immunoglobulin A vasculitis, Henoch-Schonlein purpura, pediatrics, Mycoplasma pneumoniae, renal involvement, epidemiology, retrospective study, China, seasonality, infectious triggers, vasculitis, hospitalized children
News Source: Kristina Jarvis. (October 27, 2026). Mycoplasma tops pathogen list in 119,217 hospitalized Chinese children with IgA vasculitis. Scienmag.
